Package 69238-2027-2

Brand: spironolactone

Generic: spironolactone
NDC Package

Package Facts

Identity

Package NDC 69238-2027-2
Digits Only 6923820272
Product NDC 69238-2027
Description

473 mL in 1 BOTTLE (69238-2027-2)

Marketing

Marketing Status
Marketed Since 2023-09-08
Brand spironolactone
Generic spironolactone
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "e25b36dd-7948-4481-8994-13658f1f337f", "openfda": {"nui": ["N0000175557", "N0000011310"], "upc": ["0369238202786"], "unii": ["27O7W4T232"], "rxcui": ["104232"], "spl_set_id": ["1ed9a2cb-d666-43db-b515-f9615fa6da25"], "pharm_class_epc": ["Aldosterone Antagonist [EPC]"], "pharm_class_moa": ["Aldosterone Antagonists [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (69238-2027-2)", "package_ndc": "69238-2027-2", "marketing_start_date": "20230908"}, {"sample": false, "description": "118 mL in 1 BOTTLE (69238-2027-8)", "package_ndc": "69238-2027-8", "marketing_start_date": "20230908"}], "brand_name": "Spironolactone", "product_id": "69238-2027_e25b36dd-7948-4481-8994-13658f1f337f", "dosage_form": "SUSPENSION", "pharm_class": ["Aldosterone Antagonist [EPC]", "Aldosterone Antagonists [MoA]"], "product_ndc": "69238-2027", "generic_name": "Spironolactone", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Spironolactone", "active_ingredients": [{"name": "SPIRONOLACTONE", "strength": "25 mg/5mL"}], "application_number": "ANDA215572", "marketing_category": "ANDA", "marketing_start_date": "20230908", "listing_expiration_date": "20261231"}